Regulatory Scrutiny Board Opinion/Proposal for a Regulation of the European Parliament and of the Council on monitoring and controlling drug precursors and repealing Regulations (EC) No 273/2004 and (EC) No 111/2005 (48802/EU XXVIII.GP)

EU-V: Empfehlungen und Stellungnahmen

Regulatory Scrutiny Board Opinion/Proposal for a Regulation of the European Parliament and of the Council on monitoring and controlling drug precursors and repealing Regulations (EC) No 273/2004 and (EC) No 111/2005

Erstellt am 06.06.2025

Eingelangt am 04.12.2025, Europäische Kommission - Österr. Parlament

  Aufklappen
Linkart Link
COM
COM
COM
COM
BES
VER
VER
VER
VER
VER
  Aufklappen
Interinstitutionelle Zahl
Link
2025/0384 COD
  Aufklappen
  Aufklappen
  Aufklappen
Datum Dok.Nr.
Art Betreff
03.12.2025 COM: COM(2025) 747 EUVE
Proposal for a Regulation of the European Parliament and of the Council on monitoring and controlling drug precursors and repealing Regulations (EC) No 273/2004 and (EC) No 111/2005 (Text with EEA relevance) (48801/EU XXVIII.GP)
03.12.2025 COM: SWD(2025) 397 EUB
Commission Staff Working Document/Subsidiarity Grid accompanying the document Proposal for a Regulation of the European Parliament and of the Council on monitoring and controlling drug precursors and repealing Regulations (EC) No 273/2004 and (EC) No 111/2005 (48805/EU XXVIII.GP)
03.12.2025 COM: SWD(2025) 398 EUB
Commission Staff Working Document/Impact Assessment Report accompanying the document Proposal for a Regulation of the European Parliament and of the Council on monitoring and controlling drug precursors and repealing Regulations (EC) No 273/2004 and (EC) No 111/2005 (48804/EU XXVIII.GP)
03.12.2025 COM: SWD(2025) 399 EUB
Commission Staff Working Document/Executive Summary of the Impact Assessment Report accompanying the document Proposal for a Regulation of the European Parliament and of the Council on monitoring and controlling drug precursors and repealing Regulations (EC) No 273/2004 and (EC) No 111/2005 (48803/EU XXVIII.GP)
Dok.Nr.
Links